Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Share-based Compensation: 2018-2024

Historic Share-based Compensation for Gossamer Bio (GOSS) over the last 7 years, with Dec 2024 value amounting to $20.6 million.

  • Gossamer Bio's Share-based Compensation fell 44.94% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 million, marking a year-over-year decrease of 41.80%. This contributed to the annual value of $20.6 million for FY2024, which is 27.70% down from last year.
  • Latest data reveals that Gossamer Bio reported Share-based Compensation of $20.6 million as of FY2024, which was down 27.70% from $28.5 million recorded in FY2023.
  • In the past 5 years, Gossamer Bio's Share-based Compensation ranged from a high of $42.6 million in FY2022 and a low of $20.6 million during FY2024.
  • In the last 3 years, Gossamer Bio's Share-based Compensation had a median value of $28.5 million in 2023 and averaged $30.6 million.
  • Per our database at Business Quant, Gossamer Bio's Share-based Compensation skyrocketed by 86.12% in 2020 and then crashed by 32.98% in 2023.
  • Gossamer Bio's Share-based Compensation (Yearly) stood at $38.7 million in 2020, then declined by 17.39% to $32.0 million in 2021, then spiked by 32.94% to $42.6 million in 2022, then slumped by 32.98% to $28.5 million in 2023, then dropped by 27.70% to $20.6 million in 2024.